Retainer Agreement
info@rosenlegal.com

Sage Therapeutics shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Bio-Rad Laboratories, Inc.

Rosen Law Firm, P.A., a global investor rights law firm, announces it is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. (NYSE: BIO) breached their fiduciary duties to shareholders.

Press Release

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Bio-Rad Laboratories, Inc. – BIO

New York, N.Y., June 9, 2016.  The Rosen Law Firm, P.A., a global investor rights law firm, announces it is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. (NYSE: BIO) breached their fiduciary duties to shareholders.

On November 3, 2014, Bio-Rad announced the full resolution of previously disclosed investigations by the U.S. Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) into past violations of the Foreign Corrupt Practices Act (“FCPA”) that occurred from 2005 to 2010 related to Thailand, Vietnam, and Russia.

Although the DOJ declined to prosecute Bio-Rad, the parties entered into a Non-Prosecution Agreement under which Bio-Rad has agreed to pay a penalty of $14.35 million.  Under the terms of the civil settlement with the SEC, the Company will pay $40.7 million in disgorgement and prejudgment interest.  The Company has also agreed to certain future reporting, compliance and self-monitoring provisions over the next two years.

The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Bio-Rad investors. If you own shares of Bio-Rad please visit the website at http://rosenlegal.com/cases-909.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com